Diego Signorelli
ScholarGPS® ID: 86853265962563
Affiliation History
Field
Medicine
Discipline
Oncology
Top Specialties
Cancer | Lung Cancer | Immunotherapy | Non-small-cell Lung Carcinoma | Thorax | Neoplasm | Cancer Immunotherapy | Immune Checkpoint | Chemotherapy | Checkpoint Inhibitor | Biomarker
Metrics Summary
Publication Count
104
Predicted Citations
2,406
Predicted h-index
28
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Pathologica, volume 116, issue 1, pages 13-21 (2024). |
Repotrectinib Overcomes F2004V Resistance Mutation in ROS1-Rearranged NSCLC: A Case Report (journal article) JTO Clinical and Research Reports, volume 4, issue 11, pages 100555- (2023). |
What to do after immune-checkpoint inhibitors failure in advanced non-small cell lung cancer: an expert opinion and review (journal article) Expert Review of Respiratory Medicine, volume 17, issue 9, pages 787-803 (2023). |
Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity (journal article) Cancer Research, volume 83, issue 14, pages 2283-2296 (2023). |
A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS study (journal article) Critical Reviews in Oncology/Hematology, volume 187 (2023). |
RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges (journal article) Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, volume 1877, issue 6, pages 188810- (2022). |
A Systematic Review and Meta-Analysis on the Optimal Treatment Duration of CHEckpoint InhibitoRS in Solid Tumors: The OTHERS Study (journal article) SSRN Electronic Journal (2022). |
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology (journal article) Clinical Lung Cancer, volume 23, issue 1, pages e17-e28 (2022). |
Journal for ImmunoTherapy of Cancer, volume 9, issue Suppl 2, pages A16-A17 (2021). |
P40.08 Bone-Targeted Agents Improve Survival in High Bone Tumor Burden Advanced Non-Small-Cell-Lung Cancer Patients Treated With PD-(L)1 Inhibitors (journal article) Journal of Thoracic Oncology, volume 16, issue 10, pages S1072- (2021). |
Human Vaccines & Immunotherapeutics, volume 17, issue 9, pages 2972-2980 (2021). |
Annals of Oncology, volume 32 (2021). |
Clinical and Translational Oncology, volume 23, issue 9, pages 1818-1826 (2021). |
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress–Based Treatments (journal article) Journal of Thoracic Oncology, volume 16, issue 8, pages 1298-1311 (2021). |
Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations (journal article) Translational Lung Cancer Research, volume 10, issue 6, pages 2955-2969 (2021). |
Liquid Biopsy for Small Cell Lung Cancer either De Novo or Transformed: Systematic Review of Different Applications and Meta-Analysis (journal article) Cancers, volume 13, issue 9, pages 2265- (2021). |
First Case Report of Pregnancy on Alectinib in a Woman With Metastatic ALK-Rearranged Lung Cancer: A Case Report (journal article) Journal of Thoracic Oncology, volume 16, issue 5, pages 873-877 (2021). |
Immune Checkpoint Inhibitors and Chemotherapy in First-Line NSCLC: a Meta-Analysis (journal article) Immunotherapy, volume 13, issue 7, pages 621-631 (2021). |
Critical Reviews in Oncology/Hematology, volume 160 (2021). |
P33.01 Circulating Extracellular Vesicles as Biomarkers for Immune-Checkpoint Inhibitors in Advanced NSCLC (journal article) Journal of Thoracic Oncology, volume 16, issue 3, pages S405- (2021). |